根据ESI于2020年3月12日发布的数据，我校高被引论文（Highly Cited Papers）114篇，其中热点论文（Hot Papers）8篇，见附件：2020年3月yl23455永利高被引论文及热点论文简表。详情如下。
从学科角度看，在114篇高被引论文中，临床医学最多（71篇），占比62.28%，分子生物学与遗传学（10篇）第二，占比8.77%，生物学与生物化学、药理学与毒理学均为7篇（6.14%）紧跟其后。
|
序号 |
高被引论文 Research Field |
202001 |
202003 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
56 |
58.33% |
71 |
62.28% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
11 |
11.46% |
10 |
8.77% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
6 |
6.25% |
7 |
6.14% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
6 |
6.25% |
7 |
6.14% |
|
5 |
NEUROSCIENCE & BEHAVIOR |
5 |
5.21% |
4 |
3.51% |
|
6 |
ENGINEERING |
3 |
3.13% |
3 |
2.63% |
|
7 |
MICROBIOLOGY |
1 |
1.04% |
3 |
2.63% |
|
8 |
AGRICULTURAL SCIENCES |
2 |
2.08% |
2 |
1.75% |
|
9 |
CHEMISTRY |
2 |
2.08% |
2 |
1.75% |
|
10 |
PHYSICS |
1 |
1.04% |
1 |
0.88% |
|
11 |
MATERIALS SCIENCE |
1 |
1.04% |
1 |
0.88% |
|
12 |
PSYCHIATRY/PSYCHOLOGY |
1 |
1.04% |
2 |
1.75% |
|
13 |
MULTIDISCIPLINARY |
1 |
1.04% |
1 |
0.88% |
|
14 |
合计 |
96 |
100.00% |
114 |
100.00% |
|
序号 |
2020年3月我校8篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
MINIMAL INFORMATION FOR STUDIES OF EXTRACELLULAR VESICLES 2018 (MISEV2018): A POSITION STATEMENT OF THE INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES AND UPDATE OF THE MISEV2014 GUIDELINES |
JOURNAL OF EXTRACELLULAR VESICLES 7 (1): - NOV 23 2018 |
10.1080/20013078.2018.1535750 |
BIOLOGY & BIOCHEMISTRY |
335 |
|
2 |
ALIROCUMAB AND CARDIOVASCULAR OUTCOMES AFTER ACUTE CORONARY SYNDROME |
NEW ENGLAND JOURNAL OF MEDICINE 379 (22): 2097-2107 NOV 29 2018 |
10.1056/NEJMoa1801174 |
CLINICAL MEDICINE |
261 |
|
3 |
CANCER-DERIVED EXOSOMAL MIR-25-3P PROMOTES PRE-METASTATIC NICHE FORMATION BY INDUCING VASCULAR PERMEABILITY AND ANGIOGENESIS |
NATURE COMMUNICATIONS 9: - DEC 19 2018 |
10.1038/s41467-018-07810-w |
CLINICAL MEDICINE |
38 |
|
4 |
PROTEOMICS IDENTIFIES NEW THERAPEUTIC TARGETS OF EARLY-STAGE HEPATOCELLULAR CARCINOMA |
NATURE 567 (7747): 257-+ MAR 14 2019 |
10.1038/s41586-019-0987-8 |
MULTIDISCIPLINARY |
26 |
|
5 |
EFFECTS OF ALIROCUMAB ON CARDIOVASCULAR AND METABOLIC OUTCOMES AFTER ACUTE CORONARY SYNDROME IN PATIENTS WITH OR WITHOUT DIABETES: A PRESPECIFIED ANALYSIS OF THE ODYSSEY OUTCOMES RANDOMISED CONTROLLED TRIAL |
LANCET DIABETES & ENDOCRINOLOGY 7 (8): 618-628 AUG 2019 |
10.1016/S2213-8587(19)30158-5 |
CLINICAL MEDICINE |
11 |
|
6 |
ROXADUSTAT FOR ANEMIA IN PATIENTS WITH KIDNEY DISEASE NOT RECEIVING DIALYSIS |
NEW ENGLAND JOURNAL OF MEDICINE 381 (11): 1001-1010 SEP 12 2019 |
10.1056/NEJMoa1813599 |
CLINICAL MEDICINE |
11 |
|
7 |
ALIROCUMAB IN PATIENTS WITH POLYVASCULAR DISEASE AND RECENT ACUTE CORONARY SYNDROME ODYSSEY OUTCOMES TRIAL |
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 74 (9): 1167-1176 SEP 3 2019 |
10.1016/j.jacc.2019.03.013 |
CLINICAL MEDICINE |
10 |
|
8 |
ROXADUSTAT TREATMENT FOR ANEMIA IN PATIENTS UNDERGOING LONG-TERM DIALYSIS |
NEW ENGLAND JOURNAL OF MEDICINE 381 (11): 1011-1022 SEP 12 2019 |
10.1056/NEJMoa1901713 |
CLINICAL MEDICINE |
8 |